NEW YORK (GenomeWeb News) – A microRNA called miR-21 is often over-expressed in lung cancer tumors from never-smokers, suggesting these patients may eventually benefit from treatments targeting the miRNA or other components of the same pathway.
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.
This webinar describes the optimization and validation of two commercially available next-generation sequencing assays that may be used to guide personalized cancer treatment.
This webinar will provide an overview of genomic alterations that play a role in immunotherapy response.
This online seminar will provide an overview of the use of liquid biopsies for cancer recurrence monitoring with a particular focus on colorectal cancer.
This webinar will discuss a target enrichment workflow for high-confidence detection of variants.